Monitoring the vaccine’s effectiveness and impact was crucial to know the immediate and long-term effects, as many questions remained unanswered in clinical trials.
Instituto Gulbenkian de Ciência developed several monitoring studies in different age groups of the population and of different vaccines available in the country, in partnership with hospitals, health agencies and municipalities. INFO-VAC intended to study the SARS-CoV-2 vaccine effectiveness.
The set of data collected was shared with the National Health Institute Dr. Ricardo Jorge, which was responsible along with European Agencies (ECDC) for the extended national monitoring, allowing to provide information for updates of the global policy recommendations.
INFO-VAC Healthcare Professionals
Study followed up 1250 healthcare professionals from Centro Hospitalar Lisboa Central E.P.E.